Literature DB >> 9918941

CCAAT/enhancer binding protein alpha (C/EBPalpha) is an important mediator of mouse C/EBPbeta protein isoform production.

B L Burgess-Beusse1, N A Timchenko, G J Darlington.   

Abstract

Both CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPbeta are intronless, yet can create various N-terminally truncated protein products with distinct DNA binding and transactivation potentials. These proteins can be generated via two distinct mechanisms, one translational and the other post-translational. In the translational mechanism, there is alternative translational start site selection of the different AUG codons present in the single messenger RNA (mRNA) species via a process of leaky ribosome scanning. Additionally, a post-translational method of isoform formation, through specific proteolytic cleavage of the full length protein has also been described. In this manuscript, we present evidence that the production of C/EBPbeta protein isoforms in the neonatal mouse liver is regulated by C/EBPalpha. In C/EBPalpha knockout mice, the predominant C/EBPbeta proteins are the larger 38- and 35-kd isoforms, whereas wild-type animals primarily possess the smaller 21- and 14-kd isoforms. These C/EBPalpha-dependent differences are liver specific, not present in lung or adipose tissues, and present at day 18 of development. Additionally, we show that induction of C/EBPalpha expression leads to an increase in the production of the 21-kd C/EBPbeta isoform in cell culture studies. As the various C/EBPbeta protein isoforms have different transcriptional capabilities, it is important to understand the regulation of the production of these isoforms. Our observations suggest a novel role for the C/EBPalpha transcription factor in this process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918941     DOI: 10.1002/hep.510290245

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Regulation of CCAAT/enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites.

Authors:  W Xiong; C C Hsieh; A J Kurtz; J P Rabek; J Papaconstantinou
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

Review 2.  Aging in adipocytes: potential impact of inherent, depot-specific mechanisms.

Authors:  Mark J Cartwright; Tamara Tchkonia; James L Kirkland
Journal:  Exp Gerontol       Date:  2007-03-25       Impact factor: 4.032

3.  Identification of a novel role for endothelins within the oviduct.

Authors:  Myoungkun Jeoung; Sungeun Lee; Hee-Kyung Hawng; Yong-Pil Cheon; Youn Kyung Jeong; Myung Chan Gye; Marc Iglarz; Chemyong Ko; Phillip J Bridges
Journal:  Endocrinology       Date:  2010-03-31       Impact factor: 4.736

4.  C/EBPalpha regulates generation of C/EBPbeta isoforms through activation of specific proteolytic cleavage.

Authors:  A L Welm; N A Timchenko; G J Darlington
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathway.

Authors:  Tao Lu; Ming Li; Mengnan Zhao; Yiwei Huang; Guoshu Bi; Jiaqi Liang; Zhencong Chen; Yuansheng Zheng; Junjie Xi; Zongwu Lin; Cheng Zhan; Wei Jiang; Qun Wang; Lijie Tan
Journal:  Cancer Immunol Immunother       Date:  2021-11-27       Impact factor: 6.968

Review 6.  Fat tissue, aging, and cellular senescence.

Authors:  Tamara Tchkonia; Dean E Morbeck; Thomas Von Zglinicki; Jan Van Deursen; Joseph Lustgarten; Heidi Scrable; Sundeep Khosla; Michael D Jensen; James L Kirkland
Journal:  Aging Cell       Date:  2010-08-15       Impact factor: 9.304

7.  Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.

Authors:  Shuji Sai; Cristina L Esteves; Val Kelly; Zoi Michailidou; Karen Anderson; Anthony P Coll; Yuichi Nakagawa; Takehiko Ohzeki; Jonathan R Seckl; Karen E Chapman
Journal:  Mol Endocrinol       Date:  2008-07-10

8.  C/EBPalpha is critical for the neonatal acute-phase response to inflammation.

Authors:  B L Burgess-Beusse; G J Darlington
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

9.  CCAAT/enhancer binding protein β is dispensable for development of lung adenocarcinoma.

Authors:  Yi Cai; Ayako Hirata; Sohei Nakayama; Paul A VanderLaan; Elena Levantini; Mihoko Yamamoto; Hideyo Hirai; Kwok-Kin Wong; Daniel B Costa; Hideo Watanabe; Susumu S Kobayashi
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.